| __timestamp | Jazz Pharmaceuticals plc | Takeda Pharmaceutical Company Limited |
|---|---|---|
| Wednesday, January 1, 2014 | 1172875000 | 1777824000000 |
| Thursday, January 1, 2015 | 1324803000 | 1807378000000 |
| Friday, January 1, 2016 | 1487973000 | 1732051000000 |
| Sunday, January 1, 2017 | 1618693000 | 1770531000000 |
| Monday, January 1, 2018 | 1890922000 | 2097224000000 |
| Tuesday, January 1, 2019 | 2161761000 | 3291188000000 |
| Wednesday, January 1, 2020 | 2363567000 | 3197812000000 |
| Friday, January 1, 2021 | 3094238000 | 3569006000000 |
| Saturday, January 1, 2022 | 3659374000 | 4027478000000 |
| Sunday, January 1, 2023 | 3834204000 | 4263762000000 |
| Monday, January 1, 2024 | 4263762000000 |
Unleashing insights
In the competitive world of pharmaceuticals, Takeda Pharmaceutical Company Limited and Jazz Pharmaceuticals plc have showcased distinct revenue trajectories over the past decade. Takeda, a Japanese giant, consistently outperformed with revenues peaking at approximately $4.26 trillion in 2023, marking a robust growth of over 140% since 2014. Meanwhile, Jazz Pharmaceuticals, a smaller player, demonstrated impressive growth, with revenues increasing by more than 225% from 2014 to 2023, reaching nearly $3.83 billion.
Despite the disparity in scale, both companies have shown resilience and adaptability in a rapidly evolving market. Takeda's strategic acquisitions and global expansion have bolstered its revenue, while Jazz's focus on niche markets and innovative therapies has fueled its growth. As we look to the future, the absence of 2024 data for Jazz suggests potential challenges or strategic shifts ahead.
Eli Lilly and Company and Jazz Pharmaceuticals plc: A Comprehensive Revenue Analysis
Revenue Showdown: AstraZeneca PLC vs Takeda Pharmaceutical Company Limited
Takeda Pharmaceutical Company Limited and Exelixis, Inc.: A Comprehensive Revenue Analysis
Takeda Pharmaceutical Company Limited vs Ionis Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Takeda Pharmaceutical Company Limited and Novavax, Inc.: A Comprehensive Revenue Analysis
Revenue Showdown: argenx SE vs Jazz Pharmaceuticals plc
Revenue Insights: Biogen Inc. and Jazz Pharmaceuticals plc Performance Compared
Bio-Techne Corporation vs Jazz Pharmaceuticals plc: Examining Key Revenue Metrics
Annual Revenue Comparison: Jazz Pharmaceuticals plc vs Halozyme Therapeutics, Inc.
Jazz Pharmaceuticals plc vs Amphastar Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Jazz Pharmaceuticals plc and Viridian Therapeutics, Inc.: A Comprehensive Revenue Analysis
Jazz Pharmaceuticals plc vs MiMedx Group, Inc.: Annual Revenue Growth Compared